Improved blood pressure control associated with a large-scale hypertension program.

IMPORTANCE Hypertension control for large populations remains a major challenge. OBJECTIVE To describe a large-scale hypertension program in Northern California and to compare rates of hypertension control in that program with statewide and national estimates. DESIGN, SETTING, AND PATIENTS The Kaiser Permanente Northern California (KPNC) hypertension program included a multifaceted approach to blood pressure control. Patients identified as having hypertension within an integrated health care delivery system in Northern California from 2001-2009 were included. The comparison group comprised insured patients in California between 2006-2009 who were included in the Healthcare Effectiveness Data and Information Set (HEDIS) commercial measurement by California health insurance plans participating in the National Committee for Quality Assurance (NCQA) quality measure reporting process. A secondary comparison group was included to obtain the reported national mean NCQA HEDIS commercial rates of hypertension control between 2001-2009 from health plans that participated in the NCQA HEDIS quality measure reporting process. MAIN OUTCOMES AND MEASURES Hypertension control as defined by NCQA HEDIS. RESULTS The KPNC hypertension registry included 349,937 patients when established in 2001 and increased to 652,763 by 2009. The NCQA HEDIS commercial measurement for hypertension control within KPNC increased from 43.6% (95% CI, 39.4%-48.6%) to 80.4% (95% CI, 75.6%-84.4%) during the study period (P < .001 for trend). In contrast, the national mean NCQA HEDIS commercial measurement increased from 55.4% to 64.1%. California mean NCQA HEDIS commercial rates of hypertension were similar to those reported nationally from 2006-2009 (63.4% to 69.4%). CONCLUSIONS AND RELEVANCE Among adults diagnosed with hypertension, implementation of a large-scale hypertension program was associated with a significant increase in hypertension control compared with state and national control rates. Key elements of the program included a comprehensive hypertension registry, development and sharing of performance metrics, evidence-based guidelines, medical assistant visits for blood pressure measurement, and single-pill combination pharmacotherapy.

[1]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[2]  G. Bakris,et al.  Combination Therapy With Renin‐Angiotensin‐Aldosterone Receptor Blockers for Hypertension: How Far Have We Come? , 2008, Journal of clinical hypertension.

[3]  Tom Fahey,et al.  Interventions used to improve control of blood pressure in patients with hypertension. , 2010, The Cochrane database of systematic reviews.

[4]  R. Schmieder,et al.  Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[5]  J. Grimshaw,et al.  From best evidence to best practice: effective implementation of change in patients' care , 2003, The Lancet.

[6]  D. Lackland,et al.  Translation of hypertension treatment guidelines into practice: a review of implementation. , 2011, Journal of the American Society of Hypertension : JASH.

[7]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[8]  C. Damberg,et al.  Providing Performance Feedback to Individual Physicians: Current Practice and Emerging Lessons Final Report , 2006 .

[9]  B. Sherrill,et al.  Single‐Pill vs Free‐Equivalent Combination Therapies for Hypertension: A Meta‐Analysis of Health Care Costs and Adherence , 2011, Journal of clinical hypertension.

[10]  D. Siegel.  Barriers to and Strategies for Effective Blood Pressure Control , 2005, Vascular health and risk management.

[11]  G. Bakris,et al.  Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. , 1996, Archives of internal medicine.

[12]  J. Neutel.  Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients , 2008, Current medical research and opinion.

[13]  R. Dittus,et al.  Quality Improvement Initiatives Improve Hypertension Care Among Veterans , 2009, Circulation. Cardiovascular quality and outcomes.

[14]  E. Giblin.  Controlling high blood pressure. , 1978, The American journal of nursing.

[15]  W. J. Elliott,et al.  Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: A Randomized Controlled Trial , 2009 .

[16]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[17]  J. Tuomilehto,et al.  Combination therapy in hypertension , 2007 .

[18]  D. Aron,et al.  Implementation of local guidelines for cost-effective management of hypertension , 1996, Journal of General Internal Medicine.

[19]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[20]  J. Selby,et al.  Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population , 1997, Diabetes Care.

[21]  K. McDonald,et al.  Implementing Effective Hypertension Quality Improvement Strategies: Barriers and Potential Solutions , 2008, Journal of clinical hypertension.

[22]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.